Alignment Healthcare, Inc.'s SEC filings document a Medicare Advantage operating company with common stock listed on Nasdaq under ALHC. Its Form 8-K reports furnish quarterly and annual operating results, health plan membership, revenue, adjusted gross profit, adjusted EBITDA, guidance updates and Regulation FD materials related to strategy, market position and Medicare Advantage quality ratings.
Proxy materials cover board elections, executive compensation, equity awards, pay-versus-performance data and shareholder voting matters. Registration statements, prospectus supplements and underwriting agreements describe secondary offerings of common stock by selling stockholders, the company's capital structure and related securities-law obligations.
Alignment Healthcare, Inc. (ALHC) — Form 144 filing
An insider intends to sell up to 25,000 common shares (≈0.013% of the 198,031,417 shares outstanding) through broker Justin Tabit on or about 31 Jul 2025. The shares, valued at an estimated $398,750, were originally received on 6 Oct 2014 as equity awards from Joseph Konowiecki. No related sales have been made in the past three months. The filer confirms possession of no undisclosed material adverse information and notes potential reliance on a Rule 10b5-1 trading plan.